Holen Sie sich die Stockscreener-App
95.33
2.22%
-2.16
Vorhandelsmarkt:
94.79
-0.54
-0.57%
Schlusskurs vom Vortag:
$97.49
Offen:
$96.88
24-Stunden-Volumen:
3.55M
Relative Volume:
1.64
Marktkapitalisierung:
$18.62B
Einnahmen:
$7.68B
Nettoeinkommen (Verlust:
$903.80M
KGV:
21.42
EPS:
4.45
Netto-Cashflow:
$1.14B
1W Leistung:
+1.27%
1M Leistung:
-6.51%
6M Leistung:
-12.42%
1J Leistung:
-20.54%
1-Tages-Spanne:
$95.00
$97.51
1-Wochen-Bereich:
$93.58
$99.88
52-Wochen-Spanne:
$89.92
$122.17
Zimmer Biomet Holdings Inc Stock (ZBH) Company Profile
Firmenname
Zimmer Biomet Holdings Inc
Sektor
Branche
Telefon
(574) 267-6131
Adresse
345 EAST MAIN STREET, WARSAW, IN
Vergleichen Sie ZBH mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ZBH
Zimmer Biomet Holdings Inc
|
95.33 | 18.62B | 7.68B | 903.80M | 1.14B | 4.45 |
|
ABT
Abbott Laboratories
|
128.56 | 233.05B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
102.95 | 155.05B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
386.32 | 146.77B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
84.25 | 106.66B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
76.75 | 44.02B | 5.54B | 4.18B | 623.10M | 7.00 |
Zimmer Biomet Holdings Inc Stock (ZBH) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-12-17 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2024-09-10 | Eingeleitet | Wolfe Research | Peer Perform |
| 2024-07-01 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2024-05-30 | Eingeleitet | Goldman | Neutral |
| 2024-05-21 | Hochstufung | Argus | Hold → Buy |
| 2024-01-04 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2023-10-20 | Eingeleitet | ROTH MKM | Neutral |
| 2023-08-28 | Hochstufung | BTIG Research | Neutral → Buy |
| 2023-05-03 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2023-04-11 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2023-03-31 | Hochstufung | Jefferies | Underperform → Hold |
| 2023-03-29 | Eingeleitet | UBS | Sell |
| 2023-03-10 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2023-01-09 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2023-01-05 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2023-01-03 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2022-11-23 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
| 2022-10-18 | Eingeleitet | Barclays | Underweight |
| 2022-10-12 | Eingeleitet | Jefferies | Underperform |
| 2022-05-27 | Herabstufung | Needham | Buy → Hold |
| 2022-04-13 | Herabstufung | Truist | Buy → Hold |
| 2022-04-01 | Herabstufung | Citigroup | Buy → Neutral |
| 2022-03-02 | Fortgesetzt | BofA Securities | Underperform |
| 2022-03-02 | Herabstufung | Loop Capital | Buy → Hold |
| 2022-02-08 | Herabstufung | Canaccord Genuity | Buy → Hold |
| 2022-02-08 | Bestätigt | Citigroup | Buy |
| 2022-02-08 | Bestätigt | Deutsche Bank | Hold |
| 2022-02-08 | Bestätigt | JMP Securities | Mkt Outperform |
| 2022-02-08 | Bestätigt | JP Morgan | Neutral |
| 2022-02-08 | Bestätigt | RBC Capital Mkts | Sector Perform |
| 2022-02-08 | Bestätigt | Stifel | Buy |
| 2022-02-08 | Bestätigt | Truist | Buy |
| 2022-02-08 | Bestätigt | UBS | Neutral |
| 2022-02-08 | Bestätigt | Wells Fargo | Underweight |
| 2022-02-02 | Herabstufung | UBS | Buy → Neutral |
| 2022-01-19 | Herabstufung | Wells Fargo | Equal Weight → Underweight |
| 2022-01-10 | Herabstufung | Mizuho | Buy → Neutral |
| 2022-01-07 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2022-01-04 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2021-12-10 | Eingeleitet | RBC Capital Mkts | Sector Perform |
| 2021-12-09 | Herabstufung | Needham | Strong Buy → Buy |
| 2021-12-07 | Eingeleitet | Loop Capital | Buy |
| 2021-11-23 | Herabstufung | Argus | Buy → Hold |
| 2021-09-14 | Fortgesetzt | Raymond James | Mkt Perform |
| 2021-05-25 | Eingeleitet | Barclays | Overweight |
| 2021-04-09 | Hochstufung | Northland Capital | Market Perform → Outperform |
| 2021-01-04 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2020-12-18 | Bestätigt | Needham | Strong Buy |
| 2020-10-20 | Eingeleitet | Northland Capital | Market Perform |
| 2020-09-11 | Eingeleitet | Wolfe Research | Outperform |
| 2020-08-05 | Bestätigt | Needham | Strong Buy |
| 2020-04-28 | Herabstufung | Guggenheim | Buy → Neutral |
| 2020-04-09 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2020-04-07 | Bestätigt | Needham | Strong Buy |
| 2020-03-05 | Eingeleitet | Citigroup | Buy |
| 2020-02-13 | Eingeleitet | Goldman | Buy |
| 2020-01-08 | Eingeleitet | SunTrust | Buy |
| 2020-01-07 | Hochstufung | Piper Jaffray | Neutral → Overweight |
| 2020-01-07 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2019-12-04 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2019-10-07 | Hochstufung | BTIG Research | Neutral → Buy |
| 2019-09-18 | Hochstufung | Canaccord Genuity | Hold → Buy |
| 2019-08-12 | Hochstufung | Argus | Hold → Buy |
| 2019-07-30 | Hochstufung | Barclays | Underweight → Equal Weight |
| 2019-07-29 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2019-06-11 | Hochstufung | Bernstein | Underperform → Mkt Perform |
| 2019-04-24 | Hochstufung | Needham | Buy → Strong Buy |
Alle ansehen
Zimmer Biomet Holdings Inc Aktie (ZBH) Neueste Nachrichten
Zimmer Biomet Holdings, Inc. (ZBH): Among Small-Cap Healthcare Stocks Hedge Funds Are Buying - Insider Monkey
Strong Profit Growth Highlights ZBH’s Q1 2025 - Orthopedics This Week
Zimmer Biomet (ZBH) Price Target Reduced by Canaccord | ZBH Stoc - GuruFocus
Zimmer Biomet Holdings (ZBH): Analyst Lowers Price Target, Maint - GuruFocus
Assessing Zimmer Biomet Holdings: Insights From 10 Financial Analysts - Benzinga
Zimmer Biomet (ZBH) Price Target Reduced by Canaccord | ZBH Stock News - GuruFocus
Some May Be Optimistic About Zimmer Biomet Holdings' (NYSE:ZBH) Earnings - simplywall.st
Zimmer Biomet Holdings' (NYSE:ZBH) Conservative Accounting Might Explain Soft Earnings - Yahoo Finance
Zimmer Biomet Holdings, Inc. (ZBH): Among the Best Medical Device Stocks to Buy Now - Insider Monkey
Collagen Meniscus Implant Market Is Booming So Rapidly - openPR.com
Zimmer Biomet Holdings (ZBH) Price Target Lowered by JMP Securit - GuruFocus
Total Wrist Replacement Market Top Companies StudyZimmer - openPR.com
Zimmer Biomet (ZBH) Faces Price Target Reduction Amid Mixed Outlook | ZBH Stock News - GuruFocus
Zimmer biomet updates 2025 guidance with eps range of $7.90-$8.10 amid product launches - MSN
Dental Consumables Market Projected to Hit USD 70.55 Billion by 2032 Amid Rising Demand for Aesthetic and Restorative Dental Care – SNS Insider - GlobeNewswire Inc.
Decoding Zimmer Biomet Holdings Inc (ZBH): A Strategic SWOT Insi - GuruFocus
Decoding Zimmer Biomet Holdings Inc (ZBH): A Strategic SWOT Insight - GuruFocus
Zimmer Biomet Holdings (ZBH) Target Price Lowered by Wells Fargo - GuruFocus
Zimmer Biomet Holdings (ZBH) Maintains Outperform Rating Despite Price Target Cut | ZBH Stock News - GuruFocus
These Analysts Lower Their Forecasts On Zimmer Biomet After Q1 Results - Benzinga
Zimmer Biomet Holdings (NYSE:ZBH) Q1 Earnings Rise, Revises 2025 Revenue Guidance Upward - Yahoo Finance
Zimmer Biomet Holdings (ZBH) Receives Target Price Adjustment fr - GuruFocus
Zimmer Biomet Holdings (ZBH) Price Target Lowered by Stifel Anal - GuruFocus
Zimmer Biomet Holdings (ZBH) Price Target Lowered by Stifel Analyst | ZBH Stock News - GuruFocus
Morgan Stanley Adjusts Price Target for Zimmer Biomet Holdings (ZBH) | ZBH Stock News - GuruFocus
Zimmer Biomet stock target cut to $100 by Bernstein SocGen - Investing.com UK
Zimmer Biomet Holdings (ZBH) Target Price Adjusted by Baird Anal - GuruFocus
UBS maintains sell on Zimmer Biomet stock, holds $105 target - Investing.com
UBS maintains sell on Zimmer Biomet stock, holds $105 target By Investing.com - Investing.com Nigeria
Zimmer Biomet (ZBH) Price Target Revised by Stifel Analyst | ZBH Stock News - GuruFocus
Zimmer Biomet (ZBH) Faces Price Target Reduction Amid Tariff Con - GuruFocus
Zimmer Biomet Holdings (ZBH) Target Price Lowered by Wells Fargo | ZBH Stock News - GuruFocus
Zimmer Biomet (ZBH) Sees Price Target Reduction Amid Q1 Updates - GuruFocus
Zimmer Biomet (ZBH) Stock Target Lowered as Challenges Weigh In - GuruFocus
Morgan Stanley Reduces Zimmer Biomet (ZBH) Price Target to $95 | - GuruFocus
Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Q1 2025 Earnings Call Transcript - Insider Monkey
Zimmer Biomet (ZBH) Target Price Cut by Raymond James Amid Future Tariff Concerns | ZBH Stock News - GuruFocus
Morgan Stanley cuts Zimmer Biomet stock target to $95 By Investing.com - Investing.com Nigeria
Zimmer Biomet flags $60m-$80m tariff impact on 2025 profits - Yahoo Finance
Zimmer Biomet: Stronger Cash Flows Needed Before The Stock Rebounds (NYSE:ZBH) - Seeking Alpha
Zimmer Biomet Q1 2025 net sales increase 1.1% to USD 1.909 bn - Medical Buyer
Zimmer Biomet Holdings First Quarter 2025 Earnings: EPS Beats Expectations - Yahoo Finance
Zimmer Biomet expects $60M to $80M tariff impact this year - Yahoo Finance
Morgan Stanley cuts Zimmer Biomet stock target to $95 - Investing.com
Zimmer Biomet falls 10% after narrowing its 2025 EPS guidance range - MSN
Zimmer Biomet Holdings Inc (ZBH) Q1 2025 Earnings Call Highlights: Navigating Growth Amid ... - Yahoo Finance
Zimmer Biomet Holdings Inc (ZBH) Q1 2025 Earnings Call Highlights: Navigating Growth Amid ... By GuruFocus - Investing.com Canada
Zimmer Biomet Holdings Inc (ZBH) Q1 2025 Earnings Call Highlights: Navigating Growth Amid Tariff Challenges - GuruFocus
Zimmer Biomet's Q1 earnings highlight strategic growth in orthopedic sector - Today's Medical Developments
Zimmer Biomet (ZBH) Shares Plummet Following Disappointing Q1 Re - GuruFocus
Zimmer Biomet Reports Q1 2025 Financial Results - TipRanks
Finanzdaten der Zimmer Biomet Holdings Inc-Aktie (ZBH)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.40%
2.87%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):